中西医结合颊针治疗小儿腺样体肥大临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R276.1;R246

基金项目:

广东省中医药局科研项目(20254053)


Clinical Study on Integrated Traditional Chinese and Western Medicine Buccal Acupuncture for Pediatric Adenoid Hypertrophy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察颊针联合中药及鼻用糖皮质激素治疗气虚痰凝型小儿腺样体肥大(AH) 的临床疗效,探讨颊针疗法的增效作用。方法:纳入2024年10月—2025年12月广东省中医院就诊的68例气虚痰凝型AH患儿,按照随机数字表法分为观察组和对照组各34例。治疗期间,观察组脱落3例,对照组脱落2例。对照组给予六君子汤合消瘰丸、糠酸莫米松鼻喷剂治疗,观察组在对照组基础上加用颊针治疗。疗程均为4周。比较2组治疗前后临床症状评分、腺样体体积评分、儿童阻塞性睡眠呼吸暂停生活质量量表(OSA-18) 评分及总有效率。结果:观察组总有效率为93.55% (29/31),对照组为68.75% (22/32),2 组比较,差异有统计学意义(P<0.05)。治疗后,2组张口呼吸、眠时打鼾、鼻塞、流涕、咳嗽、咽部不适、扁桃体肿大等证候评分及总分均较治疗前降低(P<0.05),且观察组张口呼吸、鼻塞、流涕评分及总分均低于对照组(P<0.05);而2组眠时打鼾、咳嗽、咽部不适、扁桃体肿大评分比较,差异无统计学意义(P>0.05)。治疗后,2组腺样体体积评分均较治疗前降低(P<0.05),且观察组腺样体体积评分低于对照组(P<0.05)。治疗后,2 组OSA-18评分均较治疗前降低(P<0.05),且观察组OSA-18评分低于对照组(P<0.05)。2组患儿在治疗中均未出现明显不良反应。结论:颊针联合中药及鼻喷剂治疗气虚痰凝型AH患儿可显著改善临床疗效,尤其在缩小腺样体体积及提高患儿生活质量方面效果显著,且无明显不良反应。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of buccal acupuncture combined with Chinese medicine and intranasal glucocorticoid in the treatment of pediatric adenoid hypertrophy (AH) of qi deficiency and phlegm coagulation type, and to explore the synergistic therapeutic effect of buccal acupuncture. Methods : A total of 68 children with AH of qi deficiency and phlegm coagulation type treated at Guangdong Provincial Hospital of Chinese Medicine from October 2024 to December 2025 were enrolled and they were randomly divided into the observation group and the control group using the random number table method,with 34 cases in each group. During treatment,3 cases dropped out from the observation group and 2 cases from the control group. The control group was treated with Liujunzi Decoction combined with Xiaoluo Pills and Mometasone Furoate Nasal Spray, while the observation group received buccal acupuncture in addition to the treatment given to the control group. Both groups were treated for four weeks. The clinical symptom scores, adenoid volume scores, and Obstructive Sleep Apnea-18 (OSA-18) quality of life scores before and after treatment, as well as the total effective rates were compared between the two groups. Results: The total effective rate was 93.55% (29/31) in the observation group and 68.75% (22/32) in the control group, with a statistically significant difference between the two groups (P<0.05). After treatment, the individual symptom scores (mouth breathing, nocturnal snoring, nasal congestion, rhinorrhea, cough, throat discomfort, tonsil enlargement) and the total symptom score decreased in both groups compared with those before treatment (P<0.05); the observation group had lower scores for mouth breathing, nasal congestion, rhinorrhea, and total symptom score than the control group (P<0.05), while no significant differences were found between the two groups in scores for nocturnal snoring,cough,throat discomfort,or tonsil enlargement (P>0.05). After treatment,the adenoid volume scores decreased in both groups compared with those before treatment (P<0.05), and the observation group had a lower adenoid volume score than the control group (P<0.05). After treatment,the OSA-18 scores decreased in both groups compared with those before treatment (P<0.05),and the observation group had a lower OSA-18 score than the control group (P<0.05). No significant adverse reactions occurred in either group during treatment. Conclusion: Buccal acupuncture combined with Chinese medicine and intranasal spray significantly improves clinical efficacy in children with AH of qi deficiency and phlegm coagulation type, with certain effects in reducing adenoid volume and improving quality of life,and shows no significant adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

张佳慧,彭桂原.中西医结合颊针治疗小儿腺样体肥大临床研究[J].新中医,2026,58(16):59-65

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-08-23
  • 出版日期:
文章二维码